Microbiome Drug Development Summit Boston, Massachusetts, USA 27-29 June 2017

Description:
Using insight gained from the most successful microbiome organizations across the globe, this forum helps emerging and well established companies discover, develop and deliver new generation of microbiome-based therapeutics.

Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement :

• Scientific Activities- Translating microbiome data into a succesful health-care product
• Clinical Activities- Obtaining decisive human data in a safe and timely manner
• Regulatory Activities- Outlining clear regulatory paths that guarantee success
• Financial Activities- Maximising shareholder value and sustaining growth

Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future.

Price
Academic: USD 1599
Industry: USD 2699

Speakers: Karim Dabbagh, Trevor Lawley, Gregory Lambert, Joseph Petrosino, Henrik Bjorn Nielsen, Colleen Cutcliffe, Xavier Maniere, Guy Harmelin, Gerard Honig, Sonia Timberlake, Rodolphe Clerval, Maireadh Pederson, Zain Kassam, Michael Step, Miguel Barbosa, Michelle Trucksis, Vince Wacher, John Hambor, Dario Gutierrez, Arpita Maiti, Dirk Gevers, Scott Jackson, Mark Bodmer, Scott Jackson, Larry Weiss, Isil Tuzun Weber, Ken Blount, Patrice Garnier, David Donabedian, Douglas Crawford, Colleen Cutcliffe, Ross Youngs, Adam D’Augelli